Holger Wesche is Chief Scientific Officer of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 52,852 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Jul 01, 2021, when has been sold 10,000 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $140,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 52.9K
0% 3M change
0% 12M change
Total Value Held $0

Holger Wesche Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 01 2021
SELL
Open market or private sale
$140,000 $14.0 p/Share
10,000 Reduced 15.91%
52,852 Common Stock
Jul 01 2021
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 13.73%
62,852 Common Stock
Apr 01 2021
SELL
Open market or private sale
$207,800 $20.78 p/Share
10,000 Reduced 15.91%
52,852 Common Stock
Apr 01 2021
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 13.73%
62,852 Common Stock
Jan 04 2021
SELL
Open market or private sale
$183,400 $18.34 p/Share
10,000 Reduced 15.91%
52,852 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 13.73%
62,852 Common Stock
Oct 01 2020
SELL
Open market or private sale
$166,100 $16.61 p/Share
10,000 Reduced 15.96%
52,669 Common Stock
Oct 01 2020
BUY
Exercise of conversion of derivative security
$6,000 $0.6 p/Share
10,000 Added 13.76%
62,669 Common Stock
HW

Holger Wesche

Chief Scientific Officer
South San Francisco, CA

Track Institutional and Insider Activities on HARP

Follow Harpoon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HARP shares.

Notify only if

Insider Trading

Get notified when an Harpoon Therapeutics, Inc. insider buys or sells HARP shares.

Notify only if

News

Receive news related to Harpoon Therapeutics, Inc.

Track Activities on HARP